Celltrion Secures Dominant Market Share in Asia Led by Autoimmune and Oncology Biosimilars
Celltrion is consolidating its leading market position across major Asian countries with its key autoimmune and oncology therapies.
Search results for "bevacizumab"
Celltrion Files for South Korean Approval of Keytruda Biosimilar CT-P51
Celltrion announced on August 24 that it has submitted a marketing authorization application to South Korea’s Ministry of Food and Drug Safety for...
Radioembolization Extends Survival in Select Patients with Advanced Liver Cancer, Study Finds
Hearing a doctor say that “the cancer has invaded the portal vein” can be deeply overwhelming for patients with liver...
From Bludgeon to Scalpel: ASCO 2026 Signals Oncology’s Shift From ‘Strong Chemo’ to ‘Right Chemo’
The standard of care in cancer treatment is undergoing a rapid paradigm shift. For decades, the default oncological...
Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR
Rznomics, a biotechnology company specializing in RNA-based gene therapies, announced on March 5 that it has been...
1